Market Segmentation
- U.S. STI & Vaginitis PCR Testing Condition Outlook (Revenue, USD Million, 2018 - 2030)
- Sexually Transmitted Infections (STIs)
- Chlamydia
- Gonorrhea
- Trichomoniasis
- Herpes Simplex Virus (HSV-1 & HSV-2)
- Human Papillomavirus (HPV)
- Syphilis
- Other
- Vaginal Infections
- Bacterial Vaginosis
- Vulvovaginal Candidiasis
- Others
- Sexually Transmitted Infections (STIs)
- U.S. STI & Vaginitis PCR Testing Test Type Outlook (Revenue, USD Million, 2018 - 2030)
- STI PCR Panels
- Vaginitis PCR Panels
- U.S. STI & Vaginitis PCR Testing End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals and Clinics
- Diagnostic Laboratories
- Homecare/At-home Testing
- Others
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Country market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Country market size and forecast for application segments up to 2030
- Company financial performance
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
